| | Per 2027 Note | | | Per 2029 Note | | | Per 2034 Note | |
Public offering price | | | %(2) | | | %(2) | | | %(2) |
Underwriting discount(1) | | | $ | | | $ | | | $ |
Proceeds before expenses, to the Issuer | | | $ | | | $ | | |
(1) | We refer to “Underwriting” beginning on page S-101 of this prospectus supplement for additional information regarding underwriting compensation. |
(2) | Plus accrued interest, if any, on the Notes from , 2024. |
Joint Book-Running Managers | ||||||||||||
| | | | | | | | |||||
Citigroup | | | HSBC | | | J.P. Morgan | | | Morgan Stanley | | | Santander |